Gálvez-Lara Mario, Corpas Jorge, Venceslá José Fernando, Moriana Juan A
Department of Psychology, University of Córdoba, Córdoba, Spain.
Maimónides Biomedical Research Institute of Córdoba, Córdoba, Spain.
Front Psychol. 2019 Jan 8;9:2674. doi: 10.3389/fpsyg.2018.02674. eCollection 2018.
Emotional Disorders (EDs) are very prevalent in Primary Care (PC). However, general practitioners (GPs) have difficulties to make the diagnosis and the treatment of this disorders that are usually treated with drugs. Brief psychological therapies may be a new option to treat EDs in a PC context. This article aims to present a study protocol to evaluate the effectiveness and the efficiency of an adaptation to brief format of the "Unified Protocol (UP) for the transdiagnostic treatment of EDs." This is a single-blinded RCT among 165 patients with EDs. Patients will be randomly assigned to receive brief psychological treatment based on UP, conventional psychological treatment, conventional psychological treatment plus pharmacological treatment, minimum intervention based on basic psychoeducational information, or pharmacological treatment only. Outcome measure will be the following: GAD-7, STAI, PHQ-9, BDI-II, PHQ-15, PHQ-PD, and BSI-18. Assessments will be carried out by blinded raters at baseline, after the treatment and 6-month follow-up. The findings of this RCT may encourage the implementation of brief therapies in the PC context, what would lead to the decongestion of the public health system, the treatment of a greater number of people with EDs in a shorter time, the reduction of the side effects of pharmacological treatment and a possible economic savings for public purse. ClinicalTrial.gov, identifier NCT03286881. Registered September 19, 2017.
情感障碍（EDs）在初级保健（PC）中非常普遍。然而，全科医生（GPs）在诊断和治疗这些通常用药物治疗的疾病方面存在困难。简短心理治疗可能是在初级保健环境中治疗情感障碍的一种新选择。本文旨在提出一项研究方案，以评估将“情感障碍跨诊断治疗统一方案（UP）”改编为简短形式的有效性和效率。这是一项针对165名情感障碍患者的单盲随机对照试验（RCT）。患者将被随机分配接受基于UP的简短心理治疗、传统心理治疗、传统心理治疗加药物治疗、基于基本心理教育信息的最小干预或仅药物治疗。结果测量指标如下：广泛性焦虑障碍量表（GAD-7）、状态-特质焦虑量表（STAI）、患者健康问卷-9（PHQ-9）、贝克抑郁量表第二版（BDI-II）、患者健康问卷-15（PHQ-15）、患者健康问卷-人格障碍模块（PHQ-PD）和简明症状量表-18（BSI-18）。评估将由盲法评分者在基线、治疗后和6个月随访时进行。这项随机对照试验的结果可能会鼓励在初级保健环境中实施简短治疗，这将导致公共卫生系统的去拥堵，在更短的时间内治疗更多的情感障碍患者，减少药物治疗的副作用，并可能为公共财政节省资金。ClinicalTrial.gov标识符：NCT03286881。于2017年9月19日注册。
